2126. Safety, Tolerability, and Pharmacokinetics (PK) in Healthy Participants Following Single Dose Administration of Zosurabalpin, a Novel Pathogen-Specific Antibiotic for the Treatment of Serious Acinetobacter Infections

BACKGROUND: Zosurabalpin is the first representative of a novel class of tethered macrocyclic peptide antibiotics active against Acinetobacter spp., including carbapenem-resistant acinetobacter baumannii-calcoaceticus (ABC) complex organisms. This presentation summarizes and discusses unpublished pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Guenther, Andreas, Millar, Laurie, Messer, Amanda, Giraudon, Mylène, Patel, Katie, Deurloo, Erik J, Lobritz, Michael, Gloge, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678405/
http://dx.doi.org/10.1093/ofid/ofad500.1749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678405/
http://dx.doi.org/10.1093/ofid/ofad500.1749

Ejemplares similares